Skip to main content
FinSpry Logo
FinSpry
ORKA logo
ORKA
(NASDAQ)
Oruka Therapeutics, Inc.
$53.31-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Oruka Therapeutics, Inc. (ORKA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Oruka Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Strong Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$62.29
↑ 16.84% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ORKA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

David Risinger
Leerink Partners
BuyMaintains
$58.00 → $86.00
Martin Fan
Wedbush
BuyReiterates
$45.00 → $45.00
Yatin Suneja
Guggenheim
Strong BuyReiterates
$60.00 → $60.00
Alex Thompson
Stifel
Strong BuyMaintains
$47.00 → $72.00
Julian Harrison
BTIG
Strong BuyReiterates
$73.00 → $73.00
Etzer Darout
Barclays
BuyMaintains
$48.00 → $50.00
Martin Fan
Wedbush
BuyMaintains
$42.00 → $45.00
Julian Harrison
BTIG
Strong BuyMaintains
$63.00 → $73.00
Michael Yee
UBS
Strong BuyInitiates
$50.00

Frequently Asked Questions

What is the analyst consensus rating for ORKA?

The analyst consensus rating for ORKA is "Strong Buy" based on 7 analyst recommendations.

What is the average price target for ORKA?

The average 12-month price target for ORKA is $62.29, representing an upside of 16.8% from the current price of $53.31.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.